Atom Investors LP Liminal Bio Sciences Inc. Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$3.94 - $6.43 $59,572 - $97,221
-15,120 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$3.68 - $11.02 $139,519 - $417,801
-37,913 Reduced 71.49%
15,120 $64,000
Q3 2020

Nov 13, 2020
BUY
$10.51 - $23.79 $299,387 - $677,681
28,486 Added 116.05%
53,033 $590,000
Q2 2020

Aug 14, 2020
BUY
$6.3 - $11.35 $154,646 - $278,608
24,547 New
24,547 $265,000

Others Institutions Holding LMNL

# of Institutions
2
Shares Held
234
Call Options Held
0
Put Options Held
0
View Full List

About Liminal BioSciences Inc.

LMNL Quotes by TradingView
  • Ticker LMNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,042,600
  • Description
  • Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...
More about LMNL
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email